Showing results (181-190 of 291) with videos related to

Sort By:
Pageof 30
Blood|November 15, 2011
Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17Hisakazu Nishimori, Yoshinobu Maeda, Takanori Teshima, et al.
International Journal of Hematology|January 6, 2026
A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasmAkira Yokota, Wataru Munakata, Toru Kiguchi, et al.
Cancer Science|July 20, 2011
Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancerTakashi Kijima, Kengo Takeuchi, Satoshi Tetsumoto, et al.
Virchows Archiv : an International Journal of Pathology|October 12, 2021
S100-negative epithelioid malignant peripheral nerve sheath tumor with possible perineurial differentiationKyoko Yamashita, Yuki Funauchi, Keiko Hayakawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 25, 2010
[Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I]Kyoko Ueda, Masahiro Yokoyama, Hiroaki Asai, et al.
Clinical Journal of Gastroenterology|April 11, 2019
Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopyTakashi Nagaishi, Daiki Yamada, Kohei Suzuki, et al.
Scientific Reports|August 22, 2023
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapyYuko Shirouchi, Noriko Nishimura, Yuko Mishima, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 26, 2026
Epithelioid Trophoblastic Tumor Presenting as a Large Cystic Mass: Diagnostic Clue From Foreign DNA Sequences Detected by Comprehensive Genomic ProfilingYui Kojima, Akiko Tonooka, Tomohiro Chiba, et al.
JCI Insight|November 2, 2023
MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGFNobuyuki Kondo, Takahiro Utsumi, Yuki Shimizu, et al.
Cancer Science|December 29, 2025
Phase 1/2 Study of Crizotinib in Children With Relapsed/Refractory ALK-Positive Anaplastic Large Cell Lymphoma or Neuroblastoma in JapanTetsuya Mori, Akiko Kada, Tomoo Osumi, et al.
Pageof 30